The ROSA Surgical Robots are designed fro neurosurgery procedures. Here are five things to know about the technology:
1. Two of the systems were sold in China, which is a key driver of the Asia market. The third was sold in India.
2. MEDTECH is targeting the China market for growth, and there are currently seven systems sold in the country.
3. The India Institute of Medical Sciences purchased the system in India. The facility treats 3,000 neurosurgery patients and 1,500 trauma patients every year.
4. The company reported consistent sales performance in Asia, due to the success of MEDTECH’s commercial activities in market.
5. There are five systems sold in the United States in the past quarter, and MEDTECH reported a 179 percent increase in revenue.
“The sale of three ROSA surgical robots in the past month, which continues to demonstrate the growing demand for precision surgical robotics both in the region and globally,” said Bertin Nahum, CEO and founder of MEDTECH.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
